Tata India Pharma & Healthcare Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 27-02-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 7.83 18.65 61.24 22.73 26.26 13.86
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 61.24 22.73 26.26 0.85 842.81
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 62.01 22.46 24.93 0.97 6,891.31
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 64.29 22.34 26.69 1.05 3,566.52
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 61.94 22.91 25.94 0.98 2,431.44
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 59.73 22.40 29.06 0.64 2,178.77
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 56.37 21.47 26.98 0.52 2,161.17

Fund Holdings as on 31-January-2024

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • LUPIN LTD

  • AUROBINDO PHARMA LTD

  • CIPLA LTD

  • DR REDDYs LABORATORIES LTD

  • DIVI LABORATORIES LTD

  • CASH / NET CURRENT ASSET

  • APOLLO HOSPITALS ENTERPRISE LTD

  • FORTIS HEALTHCARE LTD

  • ZYDUS LIFESCIENCES LTD

  • ALKEM LABORATORIES LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • AJANTA PHARMA LTD

  • FDC LTD

  • MEDI ASSIST HEALTHCARE SERVICES LTD

  • TORRENT PHARMACEUTICALS LTD

  • SANOFI INDIA LTD

  • IPCA LABORATORIES LTD

  • ORCHID PHARMA LTD

  • ASTER DM HEALTHCARE LTD

  • JUPITER LIFE LINE HOSPITALS LTD

  • INDOCO REMEDIES LTD

  • PIRAMAL PHARMA LTD

  • MEDPLUS HEALTH SERVICES LTD

  • MANKIND PHARMA LTD

  • PROCTER & GAMBLE HEALTH LTD

  • SYNGENE INTERNATIONAL LTD

  • COROMANDEL INTERNATIONAL LTD

  • AMI ORGANICS LTD

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • DEEPAK NITRITE LTD

  • A) REPO

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Fertilizers

  • Chemicals

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹842.81 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended up ₹0.08(0.28%)yesterday to ₹28.9524.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

+91 (22) 66578282
kiran@tataamc.com
+91 (22) 22613782